In re Lorazepam Clorazepate Antitrust Litigation

Full title: IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION This Order applies to…

Court: United States District Court, D. Columbia

Date published: Apr 15, 2003

MDL Docket No. 1290, Misc. No. 99ms276 (D.D.C. Apr. 15, 2003)

Opinion

MDL Docket No. 1290, Misc. No. 99ms276

April 15, 2003

ORDER

THOMAS F. HOGAN, Chief Judge

Pending before the Court is Defendant's Motion to Compel [# 320]. In light of the Court's Order on April 11, 2003 preliminarily approving the proposed settlement, it is hereby

ORDERED that the Defendants shall file a report setting forth the rationale of their Motion to Compel as that motion relates to the remaining plaintiffs in this litigation (i.e., Health Care Service Corporation, Blue Cross Blue Shield of Minnesota, Blue Cross Blue Shield of Massachusetts, and Federated Mutual Insurance Company). Such report shall be filed no later than Friday, April 25, 2003. It is further

ORDERED that the remaining plaintiffs shall have until Tuesday, May 6, 2003 to file (an) opposition(s). Any reply thereto shall be filed no later than Tuesday, May 13, 2003.

SO ORDERED.